The Mechanism of MicroRNAs Network in Alzheimer's Disease
NCT05055310 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 1000
Last updated 2021-09-24
Summary
MicroRNAs network, such as MicRNA107 et al, regulate the pathology of Alzheimer's disease and the clinical validation in diagnosis AD.
Conditions
- Alzheimer Disease
Interventions
- DIAGNOSTIC_TEST
-
MicRNAs test
plasma micRNAs concentration
Sponsors & Collaborators
-
Shanghai Mental Health Center
lead OTHER
Eligibility
- Min Age
- 60 Years
- Max Age
- 90 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2016-10-31
- Primary Completion
- 2019-12-31
- Completion
- 2019-12-31
Countries
- China
Study Locations
More Related Trials
-
Gut Microbiota and Alzheimer's Diseases
NCT03827733 ·Status: UNKNOWN
-
Screening and Evaluation of Patients With Signs and Symptoms of Alzheimer's Disease
NCT00955422 ·Status: COMPLETED
-
Monitoring Drug Efficacy in Patients with Alzheimer's Disease
NCT05801380 ·Status: RECRUITING
-
Safety and Pharmacodynamics of SHR-1707 in Alzheimer's Disease Patients
NCT06199037 ·Status: TERMINATED ·Phase: PHASE2
-
A Study of SHR-1707 in Healthy Young Adult and Elderly Subjects
NCT04973189 ·Status: COMPLETED ·Phase: PHASE1
-
Clinical Pathway for Alzheimer's Disease in China (CPAD)
NCT01779310 ·Status: COMPLETED
-
Cognitive Impairment Cohort Study of the Elderly Population in SheMountain
NCT05667935 ·Status: NOT_YET_RECRUITING
-
An Observational Study on Lecanemab Treatment for Early Alzheimer's Disease
NCT07153848 ·Status: RECRUITING
-
A Study of CM383 in Patients With Alzheimer's Disease Related Mild Cognitive Impairment and Mild Alzheimer's Disease
NCT06619613 ·Status: RECRUITING ·Phase: PHASE1
-
A Study of the Safety, Tolerability, and Pharmacodynamics of MK-8931 in Participants With Alzheimer's Disease (MK-8931-010 AM1 [P07820 AM1])
NCT01496170 ·Status: COMPLETED ·Phase: PHASE1
-
Efficacy Study of MPC-7869 to Treat Patients With Alzheimer's
NCT00105547 ·Status: COMPLETED ·Phase: PHASE3
-
Motor Slowing and Its Lesion-related Correlates in Alzheimer's Disease
NCT02811653 ·Status: UNKNOWN ·Phase: NA
-
Clinical Evaluation of Blood-Based Assays for Rapid Detection of Aβ Pathology in Alzheimer's Disease
NCT06889896 ·Status: ENROLLING_BY_INVITATION
-
Early Diagnosis and Early Treatment of Alzheimer's Disease Based on Senile Plaque Imaging
NCT02931136 ·Status: NOT_YET_RECRUITING ·Phase: PHASE4
-
Memantine Treatment in Alzheimer's Disease Patients
NCT03168997 ·Status: UNKNOWN ·Phase: PHASE4
-
Returning Research Results That Indicate Risk of Alzheimer Disease Dementia to Healthy Participants in Longitudinal Studies
NCT04699786 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
Lecanemab for Early Onset Familial Alzheimer's Disease
NCT06883019 ·Status: RECRUITING
-
The Clinical Study of Synaptic Plasticity-based Lencanumab for the Treatment of Early Alzheimer's Disease
NCT06871839 ·Status: RECRUITING
-
Hyperhomocysteinemia in Alzheimer's Disease
NCT05793372 ·Status: NOT_YET_RECRUITING
-
Biomarker Predictors of Memantine Sensitivity in Patients With Alzheimer's Disease
NCT03703856 ·Status: COMPLETED ·Phase: PHASE4
-
Study of 50561 in Patients With Mild or Moderate Alzheimer's Disease
NCT05811442 ·Status: COMPLETED ·Phase: PHASE2
-
Clinical and Genetic Study of Neurodegenerative Disorders With Cognitive Impairment
NCT00149175 ·Status: COMPLETED
-
Study of Octohydroaminoacridine Succinate Tablets in Patients With Alzheimer's Disease
NCT01569516 ·Status: UNKNOWN ·Phase: PHASE2
-
A Study of NH280105 in Healthy Adult Participants
NCT06870058 ·Status: COMPLETED ·Phase: PHASE1
-
Minocycline in Patients With Alzheimer's Disease
NCT01463384 ·Status: COMPLETED ·Phase: PHASE2